AIFM1 and lung cancer: Our studies suggests that BMP inhibition together with the mitochondrial inhibitors, Ym155 and phenformin, synergistically promote cell death of lung cancer cells that is mediated in part by “hyperactivation” of AMPK, promoting nuclear localization of AIF independent of caspase activation.